Lorazepam Tablet
Product Images NDC 72189-351

3 FDA label images from Directrx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 72189-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hjhgjghj (72189 351 02)

Hjhgjghj (72189 351 02)
Packaging label for Lorazepam C-IV 0.5 mg oral tablets by DirectRx. The label indicates the generic Ativan, each tablet containing 0.5 mg Lorazepam USP, with a package size of 2 tablets. Additional regulatory and NDC information is shown on the label.*
FDA Label Image

72189-351-30 (72189 351 30)

72189-351-30 (72189 351 30)
Packaging label for Lorazepam C-IV tablets, 0.5 mg strength, supplied as 30 tablets. The label states it is generic for Ativan and each tablet contains Lorazepam USP 0.5 mg. The product is packaged and distributed by DirectRx. The label also includes NDC number 72189-351-30 and batch information with expiration date.*
FDA Label Image

72189-351-60 (72189 351 60)

72189-351-60 (72189 351 60)
Label for Lorazepam C-IV 0.5 mg oral tablets, 60 tablets per container. The label states the generic name Lorazepam USP 0.5 mg, indicates it is generic for Ativan, and shows the lot number, expiration date of 9/30/23, and distributor DirectRx. The label includes NDC 72189-351-60 and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.